iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Mankind Pharma Ltd Option Chain

2,652.3
(0.49%)
Jul 18, 2025|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Ol (lots)Call PriceStrike PricePut PriceOl (lots)
--1,900₹0.85 0%4,2750%
--2,000₹0.4 0%10,1250%
--2,050₹0.2 0%5,4000%
2250%₹267.5 0%2,100₹0.6 -40%22,5000%
2250%₹168.65 0%2,150₹0.65 0%13,050-3.33%
3,8250%₹457 0%2,200₹1.15 0%36,675-0.60%
10,1250%₹400 0%2,250₹2.9 0%17,7750%
55,1250%₹362.1 0%2,300₹2.35 -25.39%67,050-2.29%
9,0000%₹352.1 0%2,350₹3.1 -36.73%25,4250%
54,4500%₹255 2%2,400₹6.5 -7.14%89,550-9.13%
27,225-3.96%₹209.8 -12.21%2,450₹8.8 -21.42%31,950-8.38%
68,625-1.61%₹163 -12.67%2,500₹14.5 -17.61%1,23,9753.37%
34,425-1.29%₹129 -4.44%2,550₹24 -15.78%39,6007.97%
67,950-1.30%₹95 7.46%2,600₹40.4 -9.92%66,8251.02%
96,07513.86%₹68.8 10.61%2,650₹61.9 -9.03%27,675-5.38%
1,61,775-5.01%₹47 10.71%2,700₹93.1 -6.43%27,450-7.57%
69,30017.11%₹32.5 9.79%2,750₹130.75 4.6%7,4250%
1,43,100-7.01%₹20.55 2.23%2,800₹167.9 -1.23%1,35050%
35,325-5.42%₹16.25 21.26%2,850₹212.5 -3.58%2250%
97,425-4.62%₹8.3 -12.16%2,900₹264 0%2250%
41,62511.44%₹7.75 9.15%2,950--
1,06,875-1.85%₹5.4 6.93%3,000--
51,975-9.76%₹3.55 -11.25%3,050--
27,4505.17%₹2.9 1.75%3,100--

Mankind Pharma: Related NEWS

Mankind Pharma posts mixed performance in Q4; stock slips ~4%
22 May 2025|12:15 PM

The business said that it logged a 10.70% year-on-year decline in its consolidated net profit at ₹420.80 Crore for Q4FY25.

Read More
Top Stocks for Today - 22nd May 2025
22 May 2025|06:38 AM

Here are some of the stocks that may see significant price movement today: NBCC, IndusInd Bank, Hindustan Zinc, etc.

Read More
Mankind Pharma Faces ₹183.11 Crore Tax Demand
30 Mar 2025|04:34 PM

The cumulative demand, including interest charges, is ₹183.11 crore.

Read More
Mankind Pharma Merges Three Subsidiaries
30 Mar 2025|01:33 PM

The merger took effect on March 29, 2025, after all necessary regulatory approvals were obtained.

Read More
Mankind Pharma Faces ₹111.68 Crore Tax Demand, Plans to Appeal
28 Feb 2025|11:13 PM

The tax adjustments pertain to Section 80IC/80IE, which involves deductions for businesses in special economic zones, and a disallowance of certain expenditures under Section 37(1) of the Act.

Read More
Top Stocks for Today - 24th January 2025
24 Jan 2025|07:50 AM

Here are some of the stocks that may see significant price movement today: Indus Towers, Dr Reddy’s Laboratories, Mankind Pharma, etc.

Read More
Mankind Pharma Q3 Profit Falls 16%, Revenue Jumps 24%
23 Jan 2025|11:57 PM

The company reported a good growth in EBITDA of 36.8% to ₹830 crore in the quarter against ₹606.5 crore in Q3 FY24.

Read More
Mankind Pharma Secures ₹5,000 Crore NCDs by Pledging 56.31% Stake in BSV
8 Jan 2025|04:01 PM

The NCDs issued are categorized, rated, secured, redeemable, and transferable, distributed across three series.

Read More
Mankind Pharma, Innovent Join Forces for Cancer Care
26 Dec 2024|12:46 PM

According to the National Cancer Registry Programme, cancer is expected to cause 29.8 million DALYs by 2025, making it a serious health issue in India.

Read More
Mankind Pharma Secures ₹3,000 Crore via QIP for Growth
20 Dec 2024|02:06 PM

The issue price includes a premium of ₹2,519 per share, aggregating a total of ₹2,999.99 crore.

Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.